...
首页> 外文期刊>Pediatric Research >EFFECTS OF DEXAMETHASONE (DXM) ON CHEMOTACTIC ACTIVITY AND INFLAMMATORY INDICATORS IN TRACHEAL ASPIRATES OF PRETERM INFANTS AT RISK FOR CHRONIC LUNG DISEASE (CLD)
【24h】

EFFECTS OF DEXAMETHASONE (DXM) ON CHEMOTACTIC ACTIVITY AND INFLAMMATORY INDICATORS IN TRACHEAL ASPIRATES OF PRETERM INFANTS AT RISK FOR CHRONIC LUNG DISEASE (CLD)

机译:地塞米松(DXM)对有慢性肺病(CLD)危险的早产儿气管吸取物中化学活性和炎症指标的影响

获取原文
           

摘要

To evaluate the effect of Dxm on the inflammatory process in the early phase of CLD (postnatal age 10-16 days), tracheal aspirate fluid (TAF) from 16 preterm infants (BW 891 ± 46 gms, GA 27.1 ± 0.4 wks, mean ± SEM) was assessed for chemotactic activity and indicators of inflammation. After Dxm therapy chemotactic response of blood neutrophils exposed to TAF decreased (migratory distance before Dxm 150 ±10um, after Dxm 91 ±11μm, p<0.001); additionally the influx of TAF-neutrophils was reduced (before Dxm 492 ±165 cells/μl effluent, after Dxm 77 ± 22, p<0.01) Elastase-alpha-1-Proteinaseinhibitor(a-1-PI)- complex decreased after treatment (before Dxm 534 ± 154, after Dxm 65 ±18 ng /ml, p<0.01). Before Dxm, free elastolytic activity was only present in one infant, 15/16 had a protective activity of a-1-PI. Concentrations of albumine were lower after Dxm(before Dxm 29 ±6, after Dxm 7 ±1 mg/dl, p<0.001), Interleukin-1 similary decreased. The reported effects could not be observed in untreated control infants (n=8). We conclude that Dxm reduces the pulmonary inflammatory reaction of preterm infants during the early phase of CLDSupported by a grant of Deutsche ForachungegemeinBchaft (Sp 239/3-1).
机译:为了评估Dxm对CLD早期(出生后10-16天),16例早产儿(BW 891±46 gms,GA 27.1±0.4 wks,均值±)的气管抽吸液(TAF)炎症过程的影响SEM)评估了其趋化活性和炎症指标。 Dxm治疗后,暴露于TAF的血液中性粒细胞的趋化反应降低(Dxm之前的迁移距离为150±10um,Dxm之后的迁移距离为91±11μm,p <0.001);此外,TAF中性粒细胞的流入减少(在Dxm 492±165细胞/μl流出之前,在Dxm 77±22之后,p <0.01)处理后弹性蛋白酶-α-1-蛋白酶抑制剂(a-1-PI)-复合物减少( Dxm 534±154之前,Dxm 65±18 ng / ml之后,p <0.01)。在Dxm之前,仅一名婴儿中存在游离的弹性蛋白酶活性,15/16具有a-1-PI的保护活性。 Dxm后白蛋白浓度较低(Dxm前为29±6,Dxm后为7±1 mg / dl,p <0.001),白介素-1的相似性降低。在未治疗的对照婴儿中未观察到报道的效果(n = 8)。我们得出的结论是,Dxm在CLD早期减少了早产儿的肺部炎症反应,这要归功于Deutsche ForachungegemeinBchaft(Sp 239 / 3-1)的资助。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号